Or to put it more bluntly, the Ministry of Finance has no control over how to spend the 5 billion yuan. They just helped Xu Qiu keep the account book, and in the end, Xu Qiu had the final say.

"Doctor Xu, although it is more than 5 billion, everyone adds a few hundred yuan, so it won't be spent... We still have to save money!" A few drops of sweat appeared on the face of the director of the Finance Ministry and quickly persuaded.

Xu Qiu nodded after thinking about it.

The Finance Director was about to breathe a sigh of relief, but listened to Xu Qiu: "Then let's get a little less."

A part of the budget of 5 billion is specially prepared for the high salary of researchers...

Just like at Linhai Artificial Vascular Research Institute.

Working at Xu Qiu's hands will definitely be far beyond the industry average, and the salary will be very high.

Needless to say, dedicating to the progress of human medicine, this sentence is noble to self-restraint, but imposing it on others is despicable.

What Xu Qiu could do was provide salary that matched his workload. After enough money was given, the employees begged the boss to use them as beasts...

"The second gear has been increased to 45,000."

"The third level has increased from an average of 15,000 to 23,000."

"Researchers at all levels generally increase their salary by 10,000 yuan!"

"In addition, as long as a team produces major results, rewards of 500,000 to 1.5 million yuan according to their importance!"

As for academicians... people of this level no longer care about that little salary. The resources they possess are unimaginable to ordinary people. Money is a number for them, and what makes them even more moved is to personally participate in a great project.

Their greatest pursuit is to be recorded in history.

When Xu Qiu announced the amount of salary increase, the Finance Director was completely stunned.

Is there anyone who raises salary like this? It can be increased by 10,000 yuan. The salary level of the research staff of the Xinli Medicine Department is already very high, but it even needs to be raised a lot!

Working in the new liver medicine department for half a year, almost the same as in the original unit for two or three years!

and.

Nowadays, the industry is generally intravenous and the work pressure is getting greater and greater. Where is it not 996,007, and I have never seen anyone take the initiative to pay employees...

"Doctor Xu..." The director of finance hesitated for a moment. Although the salary system of Lin Medical was also greatly reformed by Xu Qiu and the doctor's salary was also high, he still felt that the salary increase in the new liver medicine department was too outrageous.

Xu Qiu interrupted him with a head shake and said, "No need to say more, go and execute it."

"Yes..." The Finance Director also knew Xu Qiu's character and no longer refuted it.

The next day, a salary adjustment announcement was issued and issued to all researchers' mobile phones.

For a moment, Baiyun Drug Research and Development Institute was too quiet.

Everyone stared at the text messages in their hands with incredible eyes...

"Another salary increase?"

"My salary is much higher than my original unit, and the work intensity is actually similar to before, so now I'm adding more money?"

"Is this the treatment of Linhai Artificial Vascular Research Institute a few years ago? I understand why those people were so devoted to Xu Qiu!"

"Where is doing scientific research, it's not 996,007, but Dr. Xu has enough money here!"

"Overage work is three times the average, and five times the holidays, this is a gift!"

"Can you add a bed to the laboratory? I suddenly feel like developing all the homes..."

"Monthly salary is 23,000, and my life is all about Dr. Xu!"

The researchers all went crazy.

In their original unit, the salary was only 10,000 or 12,000, but now it has almost doubled. Although the workload is amazing, it is actually not much different from before.

At this moment, no matter what Xu Qiu is, he is a genius in the medical field or a scientific research genius, he is the god in the eyes of researchers!

Researchers are also humans, and they also have parents. Most of them carry mortgage loans and car loans. After working for Xu Qiu for the past six months, they will no longer have to worry about the pressure of repaying the loan in the next few years!

This hasn't added the various bonuses in the project.

And after the R&D results, the huge rewards for the whole group!

"Doctor Xu, please don't treat me as a human being!"

"If you work hard, as long as the project is successful, we will have a strong job in the rest of our life, and we will not be short of money!"

"Working overtime, today I will study the disc-domain receptor 1!"

"We must produce some important results. If we get a bonus of 1.5 million, our team will take off directly!"

...

Two weeks later, a complete target research report was delivered to Xu Qiu.

After countless desperate efforts, eleven of the potential targets provided by Xu Qiu were confirmed to have R&D value.

The first is CRM197.

The second is DDR1, also known as disc-domain receptor 1, which is upregulated in hepatocellular carcinoma tissues, and the expression in stage II-IV hepatocellular carcinoma tissues in TNM tumor staging system is higher than in stage I hepatocellular carcinoma tissues in TNM tumor staging system, and the high expression of DDR1 is related to poor prognosis.

Moreover, the research institute on DDR1 is also the most in-depth. Now, the mechanism of interaction between DDR1 and AFR6 has been discovered, and it is confirmed that DDR1 and ARF6 can be used as new prognostic markers and therapeutic targets for metastatic liver cancer.

Secondly, the filamentin phosphatase 3 and SSH3, which plays an extremely important role in the occurrence of liver cancer, especially in hepatocellular carcinoma, SSH3 is positively correlated with pathological staging and tumor size...

There is also CBX6, which is chromatin binding protein 6. After multifunctional analysis, it is suggested that its increased expression in hepatocellular carcinoma is an independent adverse prognostic factor.

More importantly, once patients with hepatocellular carcinoma are diagnosed with overexpression of CBX6, they basically have the characteristics of fast tumor growth, strong invasion ability, and high clinical stage...

This means that CBX6 may be closely related to the progression of liver cancer.

Subsequent targeted research concluded that CBX6 can enhance the invasion and metastasis ability of liver cancer cells by regulating the epithelial-mesenchymal transformation mechanism mediated by the transcription factor Snail/ZEB1!

And this almost puts a perfect target in front of everyone - as long as CBX6 can be inhibited, the occurrence and development of liver cancer will be greatly curbed!

In addition, there are steroid 5α-reductase 3 (SRD5A3), myosubtibin-related protein 14 (MTMR14), differentiation inhibitor 1 (ID1), pescadillo ribosomal biogenesis factor 1 (PES1), etc.

These targets have their own advantages. Some are more suitable for affecting the proliferation and tumorigenesis of liver cancer, some can play an important role in blocking tumor development, and several are particularly restraining liver cancer metastasis.

"It's the New Year in the field of liver cancer drug research and development..." Mo Wan's eyes straightened as she looked at the documents on Xu Qiu's desk.

When will new targets be so easy to find?

For a target, other pharmaceutical companies often need to spend a lot of money, countless manpower, and months, or even years to find effective goals.

Xu Qiu only took one month to screen out eleven targets with great potential...

Not to mention anything else, even if Xu Qiu's research is suspended, he can still make huge profits!
Chapter completed!